Dynamic S-acylation controls CMG2 maturation, extracellular matrix regulation, and anthrax toxin entry
Abrami, L.; Blaskovic, S.; Joliot, O.; Mercier, V.; Kunz, B.; mesquita, F. S.; van der Goot, F. G.
Show abstract
CMG2/ANTXR2 functions as a Collagen VI receptor and the primary portal for anthrax toxin entry. We find that CMG2 is regulated by ordered cycles of S-acylation and deacylation throughout its life cycle. Following synthesis in the endoplasmic reticulum, acylation by ZDHHC7 on two juxtamembrane cysteines protects folding intermediates from ER-associated degradation, resulting in a 5-fold increase in CMG2 biogenesis. The cytosolic thioesterase APT2 can remove these acyl chains, thereby controlling CMG2 levels. In the Golgi, CMG2 acylation by ZDHHC3 on a third cysteine to permit Arf6-dependent transport to the plasma membrane. At the cell surface, S-acylated CMG2 recruits APT2 in response to ligand binding, enabling release from the actin cytoskeleton and endocytosis. Accordingly, blocking APT2 suppresses the intracellular delivery of anthrax toxin, and inhibits CMG2-dependent Collagen VI degradation. These results define S-acylation-deacylation cycles as key regulators of CMG2 biogenesis and function, and highlight APT2 inhibition as a strategy to modulate CMG2 levels or prevent anthrax intoxication.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.